Genentech
South San Francisco, California, United States · Biotechnology, Health Care, Manufacturing
Genentech is passionate about finding solutions for some of the world’s most difficult-to-treat conditions, using cutting-edge science to create and deliver innovative medicines worldwide. With a belief that science is personal, Genentech is dedicated to making a difference in the lives of millions and invites those who share this mission to explore career opportunities at gene.com/careers.
Key facts
- Headquarters
- South San Francisco, California, United States
- Employees
- 14,000
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- gene.com
- Company page
Recent activity at Genentech
- : Mark Andrews Partners with Genentech to Raise Awareness for Diabetic Macular Edema.
- : Genentech Enters Agreement with U.S. Government to Lower Prescription Drug Costs and Enhance Patient Access.
- : Genentech Appoints Zoë Harris Lazarre as Chief Marketing Officer
- : Departure of Alexander Hardy & Appointment of Interim Chief Exec Officer at Genentech
Leadership
- Zoë Harris Lazarre, Chief Marketing Officer
- Ashley Magargee, Chief Executive Officer
Verified email and direct lines for Genentech’s decision-makers are on Fundz. See plans
Genentech in the news
- Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon - Business Wire (Sep 28, 2026)
- FDA Grants Priority Review to Genentech's Enspryng for Thyroid Eye Disease, Setting Up First At-Home Subcutaneous Option - BioPharm International (Jun 30, 2026)
- SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal - Pharmaceutical Technology (Feb 03, 2026)
- Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration - Genetic Engineering and Biotechnology News (Feb 02, 2026)
- Scoring gene importance by interpreting single-cell foundation models - nature.com (May 27, 2026)
- SanegeneBio Enters $1.5 Billion Exclusive Global License Agreement with Genentech for RNAi Program - Pharmaceutical Executive (Feb 03, 2026)
- Redefining Drug Discovery with AI - Genentech (Mar 18, 2024)
- Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center (Apr 19, 2026)
Companies similar to Genentech
- Vectura Group Limited · Biotechnology, Health Care, Manufacturing, Medical, Therapeutics
- Celldex · Biotechnology, Health Care, Medical, research, Therapeutics
- Aptose Biosciences · Biotechnology, Health Care, Medical, research, Therapeutics
- SymPhysis Medical · Biotechnology, Health Care, Manufacturing, Medical, Therapeutics
- Swarm Oncology Ltd · Biotechnology, Health Care, Medical, research, Therapeutics
About Genentech: questions and answers
What does Genentech do?
Genentech is passionate about finding solutions for some of the world’s most difficult-to-treat conditions, using cutting-edge science to create and deliver innovative medicines worldwide. With a belief that science is personal, Genentech is dedicated to making a difference in the lives of millions and invites those who share this mission to explore career opportunities at gene.com/careers.
Where is Genentech headquartered?
Genentech is headquartered in South San Francisco, California, United States.
How many employees does Genentech have?
Genentech has about 14,000 employees.
Who leads Genentech?
Ashley Magargee is a Chief Executive Officer at Genentech.
What is the latest news on Genentech?
On Jun 30, 2026, Mark Andrews Partners with Genentech to Raise Awareness for Diabetic Macular Edema.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy